The Circuit – Quarterly Brain Health News – September 2021
September 30, 2021Read moreRead an important message from our CEO & President, learn about our latest initiatives and more.
Video: A Conversation with Veteran BASE Jumpers of 22 Jumps
September 30, 2021Read moreCohen Veterans Bioscience hosts a conversation with Veteran BASE Jumpers of 22 Jumps.
Cross-Platform Evaluation of Commercial Metabolomics Platforms to Support Precision Therapeutics Research
September 30, 2021Read moreAs part of its RAPID-DxTM (Research Alliance for Precision Therapeutics, Innovation and Diagnostics) program, researchers from Cohen Veterans Bioscience (CVB) and collaborators conducted a blinded cross-platform analysis (or “bakeoff”) of commercially available assay platforms to inform selection in the conduct of neuropsychiatric biomarker research.
Q&A with CVB Chief Technology Officer Eugene Rakhmatulin on Challenges & Opportunities in Brain Health Research
September 30, 2021Read moreChief Technology Officer Eugene Rakhmatulin discusses how CVB’s use of cutting-edge technology is helping to advance research for trauma-related brain disorders, such as PTSD and TBI.
Reflections On The Impact Of 9/11 From A Secret Service Agent Who Was There – And Whose Family Was Forever Changed
September 10, 2021Read more“We must never forget the many sacrifices founded on love that these valiant warriors, military or civilian, made for their teammates, families and nation so that we may continue to live free, healthy and secure.”
News
Cohen Veterans Bioscience > News
WHO WE ARE
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Learn More Donate
